Esculetin may alleviate mitochondrial dysfunction by inducing PINK1/Parkin mediated mitophagy, suggesting that esculetin is expected to become an effective therapy to prevent AKI-diabetes comorbidity (Dagar N,et al., 2024). This evidence concerns the gene PINK1 and diabetes mellitus.